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Viruses are the major pathogens of community-acquired 
(CA) acute gastroenteritis (AGE) in children, but their role in 
healthcare-associated (HA) AGE is poorly understood. Chil-
dren with AGE hospitalized at Alder Hey Children’s Hospital, 
Liverpool, UK, were enrolled over a 2-year period. AGE was 
classiﬁ  ed as HA if diarrhea developed >48 hours after ad-
mission. Rotavirus, norovirus, adenovirus 40/41, astrovirus, 
and sapovirus were detected by PCR. A total of 225 chil-
dren with HA-AGE and 351 with CA-AGE were enrolled in 
the study. HA viral gastroenteritis constituted one ﬁ  fth of the 
diarrheal diseases among hospitalized children and com-
monly occurred in critical care areas. We detected >1 virus 
in 120 (53%) of HA-AGE cases; rotavirus (31%), norovirus 
(16%), and adenovirus 40/41 (15%) were the predominant 
viruses identiﬁ  ed. Molecular evidence indicated rotaviruses 
and noroviruses were frequently introduced into the hospital 
from the community. Rotavirus vaccines could substantially 
reduce the incidence of HA-AGE in children.  
E
nteric viruses are major etiologic agents of acute gas-
troenteritis (AGE) among infants and young children 
worldwide (1). Rotavirus is the most common single cause 
of severe diarrhea leading to dehydration and death (2). 
Other recognized viral causes of pediatric gastroenteritis 
include norovirus, astrovirus, enteric adenovirus (serotypes 
40 and 41), and sapovirus (1).
Although studies of viral gastroenteritis in children 
have mainly focused on community-acquired (CA) infec-
tion, the importance of healthcare-associated (HA) rotavirus 
infection and the potential for its prevention by vaccination 
has been highlighted in several recent publications (3–8). 
Despite improved understanding of the disease impact and 
epidemiology of HA rotavirus gastroenteritis, many studies 
have been limited by inadequate design and methodology, 
short duration, and small size.
The value of molecular methods in deﬁ  ning the con-
tribution of multiple viruses to pediatric diarrheal disease 
is being increasingly recognized (9,10). However, no stud-
ies have examined each of the known viral gastroenteritis 
agents among children with HA-AGE. In a 2-year prospec-
tive study in a large pediatric hospital, we examined the 
contribution to HA-AGE and CA-AGE of rotavirus and 4 
additional enteric viruses using the most sensitive molecu-
lar detection methods available.
Materials and Methods
Study Setting
The study was conducted at the Royal Liverpool Chil-
dren’s National Health Service Foundation Trust (Alder 
Hey Hospital). Alder Hey provides primary, secondary, 
and tertiary care facilities for >200,000 children each year 
and has ≈300 inpatient beds. General medicine, general 
surgery, and a range of specialist services including critical 
care, oncology, cardiac, and neurosurgery are provided.
Enrollment Procedures
Children <16 years of age who were admitted with 
AGE during January 1, 2006–December 31, 2007, or 
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those in whom AGE developed after hospitalization, were 
eligible for inclusion in the study. AGE was deﬁ  ned as 
diarrhea (≥3 loose, or looser-than-normal, stools in a 24-
hour period), with or without vomiting, of <7 days’ du-
ration. Gastroenteritis was considered HA if symptoms 
developed ≥48 hours after admission. Written informed 
consent was obtained from the child’s parent or guardian 
before enrollment.
Collection of Clinical Data and Fecal Specimens
Study nurses identiﬁ   ed case-patients by daily chart 
review. Clinical data were collected when patients were 
admitted and prospectively until hospital discharge. We 
used these data to calculate a severity score using a modi-
ﬁ  ed 20-point scoring system (Table 1). A stool sample was 
collected as soon as possible after onset of diarrhea. Fecal 
specimens were stored at −80°C until virus detection was 
undertaken. Rates of AGE were calculated by using total 
admission numbers obtained from hospital records.
Laboratory Analyses
Virus Detection
Nucleic acid was extracted from 10% fecal suspensions 
in phosphate buffered saline by using the RNeasy mini kit 
(QIAGEN, Crawley, UK). After reverse transcription–PCR 
(RT-PCR) was performed by using random hexamers, ro-
tavirus, adenovirus 40/41, astrovirus, and sapovirus were 
each detected by conventional PCR using virus-speciﬁ  c 
primers, agarose gel electrophoresis, and ethidium bromide 
staining (9,12).  Norovirus was detected by using a modiﬁ  -
cation of the real-time PCR method of Kageyama et al. (13) 
as described by Amar et al. (9).
Molecular Characterization of 
Rotaviruses and Noroviruses
Rotavirus viral protein (VP) 7 (G) and VP4 (P) were 
genotyped by using multiplex, heminested RT-PCR (14,15). 
The dsRNA genomes of genotype P[8],G1 rotavirus strains 
were examined by polyacrylamide gel electrophoresis 
(PAGE). The VP7 gene of P[8],G1 rotavirus strains was 
ampliﬁ  ed by RT-PCR using primers 9con1 and 9con2 (15). 
The capsid region of Norovirus genogroup II strains was 
ampliﬁ  ed by RT-PCR using primers G2SKF and G2SKR 
(16). All RT-PCR ampliﬁ  cation products were puriﬁ  ed by 
using Micro-spin columns (GE Healthcare, Buckingham-
shire, UK), and sequenced by Cogenics (Hope End, Essex, 
UK). Phylogenetic trees were constructed according to the 
neighbor-joining method (17) in the ClustalW software 
package (18).
Results
Subject Enrollment and Case Classiﬁ  cation
AGE in 669 children met the case deﬁ  nition for inves-
tigation during the study. We excluded 93 children from 
analysis because of failure to obtain fecal specimens (80 
children), consent refusal/withdrawal (12), and age >16 
years (1). Of the remaining 576 children with AGE, 351 
cases (61%) were determined to be CA and 225 (39%) 
were HA.
Virus Detection Rates
During the study period, ≥1 viruses were detected in 
339 (59%) of 576 specimens. Rotavirus was identiﬁ  ed most 
frequently (38% of all AGE cases), followed by norovirus 
(16%), adenovirus 40/41 (14%), astrovirus (5%), and sapo-
virus (5%) (Table 2). The order of detection of each virus 
did not differ between CA- and HA-AGE cases. We detect-
ed >1 virus in 120 (53%) of 225 HA-AGE cases. Rotavirus 
was detected in 70 (58%) of 120 children with HA-AGE in 
whom a virus was identiﬁ  ed.
In 98 (17%) of 576 children with AGE, >1 virus was 
detected; this proportion did not signiﬁ  cantly differ be-
tween CA (65/351 cases, 19%) and HA (33/225, 15%) 
infection. Rotavirus was the agent least likely to be identi-
ﬁ  ed as a mixed infection; it occurred as the only virus in 
144 (65%) of 220 AGE cases in which it was identiﬁ  ed. 
56  Emerging Infectious Diseases • www.cdc.gov/eid • Vol. 16, No. 1, January 2010
Table 1. Modified 20-point scoring system used to evaluate 
severity of gastroenteritis (11)
Clinical sign or symptom  Points
Duration of diarrhea, d 
 <2  1
 2–4  2
 >4  3
Maximum no. diarrheal stools in 24 h 
 3  1
 4–5  2
 >5  3
Duration of vomiting, d 
 No  vomiting  0
 1–2  2
>33
Maximum no. vomiting episodes in 24 h 
 1  1
 2  2
>33
Rehydration 
 None  0
 Oral  1
 Intravenous  2
Fever, ºC  
 <37.6  0
 37.6ºC–38.5  2
 >38.5  3
Behavior
 Normal  0
 Lethargic/irritable  1
 Convulsion  3Viral Gastroenteritis among Hospitalized Children
This proportion did not differ between patients with CA 
(100/150, 66%) and HA (44/70, 62%) rotavirus infection 
(Table 3). Sapovirus was least likely to be identiﬁ  ed as a 
sole infection, with only 4 (15%) of 27 cases involving no 
other virus.
Age Distribution of Case-patients
The median age of children with all-cause CA-AGE 
(10 mo, range 1–180 mo) did not differ from children with 
all-cause HA-AGE (12 mo, range 1–192 mo). Among case-
patients, the median age of children with rotavirus infection 
(11 mo, range 1–192 mo) was similar to children excreting 
norovirus (10 mo, range 1–180 mo); adenovirus 40/41 (10 
mo, 1–180 mo); astrovirus (9 mo, 1–180 mo); and sapovi-
rus (12 mo, 1–96 mo). The median age of children excret-
ing any virus did not differ according to exposure setting 
(data not shown).
Severity of Viral Gastroenteritis
The severity of AGE caused by infection only with ro-
tavirus or norovirus was greater than with other viruses for 
CA and HA infections (Table 4). The proportion of children 
with severe gastroenteritis (deﬁ  ned as severity score ≥11) 
was greatest with rotavirus (42/144, 29%) and norovirus 
(12/46, 26%) and lowest for children in whom virus was 
not detected (39/237, 16%). Rotavirus was associated with 
severe illness in 36% of HA-AGE cases in which it was 
identiﬁ  ed as the only infection, not signiﬁ  cantly different 
to the proportion (24%) of HA-AGE judged to be severe as 
a consequence of single norovirus infection (p = 0.400 by 
Fisher exact test). Overall, 28% of HA-viral gastroenteritis 
patients were deﬁ  ned as having severe disease.
Molecular Epidemiology of Virus Infections
Rotavirus genotype could be determined for 93 (62%) 
of 150 CA-AGE cases and for 23 (33%) of 70 HA-AGE 
cases (rotaviruses that could not be genotyped were con-
sidered to contain insufﬁ  cient virus load in stool [data not 
shown]). Distribution of rotavirus strains did not differ be-
tween CA and HA cases, with the P[8],G1 strain predomi-
nating in each. Thus, of rotaviruses genotyped from 93 
patients with CA rotavirus, genotypes of 62 gastroenteritis 
patients were P[8], G1; 7 were P[8], G3; 4 were P[4], G2; 
18 were P[8], G9; and 1 was P[8], G4; 1 strain could not 
be G or P typed. Of rotaviruses genotyped from 23 patients 
with HA rotavirus gastroenteritis, 19 were P[8], G1; 1 was 
P[8], G3; 2 were P[4], G2; and 1 was P[4], G1 + G2.
To explore whether HA-AGE cases were associated 
with similar or identical rotavirus strains causing CA-AGE, 
we examined P[8], G1 rotaviruses further by PAGE and 
by VP7 gene sequencing. Three distinct electropherotypes 
(L1, L2, and L3) were identiﬁ  ed among 19 HA P[8], G1 
strains, and each of these electropherotypes also was rec-
ognized among 7 electropherotypes assigned to 62 CA 
P[8], G1 strains (data not shown). Similarly, all except 2 
VP7 nucleotide sequences from HA-AGE rotavirus infec-
tions clustered with corresponding sequences from CA 
strains with which they shared almost identical or identical 
nucleotide sequence (Figure 1). For noroviruses, all except 
1 HA-AGE norovirus sequences were identical, or almost 
identical, to those derived from CA strains (Figure 2).
Hospital Distribution of Viral Gastroenteritis Cases
Although 274 (94%) of 291 patients with CA viral gas-
troenteritis were located in acute general medical and sur-
gical wards, 88 (56%) of 157 with HA viral gastroenteritis 
were located elsewhere in the hospital. In particular, the 
highest rates of HA viral gastroenteritis infection were noted 
in critical care units (intensive care unit and high dependency 
unit), neurology, cardiology, and long stay wards where chil-
dren with chronic conditions who have complex healthcare 
needs are patients (although this represents <5 case-patients) 
(Figure 3). Median duration of hospital stay before onset of 
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Table 2. Virus detection rates by case origin, Royal Liverpool 
Children’s NHS Foundation Trust (Alder Hey Hospital), Liverpool, 
UK*
Virus
HA-AGE cases,  
no. (%), n = 225 
CA-AGE cases,  
no. (%), n = 351 
Rotavirus 70 (31)  150 (43) 
Norovirus 36 (16)  54 (15) 
Adenovirus 40/41 34 (15)  49 (14) 
Astrovirus 12 (5)  16 (5) 
Sapovirus 5 (2)  22 (6) 
Any virus detected 120 (53)  219 (62) 
No virus detected  105 (47)  132 (38) 
*CA-AGE, community-acquired acute gastroenteritis; HA-AGE, healthcare-
associated acute gastroenteritis. 
Table 3. Mixed virus infections by case origin, Royal Liverpool Children’s NHS Foundation Trust (Alder Hey Hospital), Liverpool, UK* 
Virus Total  Rotavirus  Norovirus 
Adenovirus
40/41 Astrovirus Sapovirus >2 viruses 
Rotavirus 76 14 16 3 10 7
Norovirus 44 6 6 2 3 4
Adenovirus 40/41 48 10 2 1 2 5
Astrovirus 16 4 2 2 0 2
Sapovirus 23 1100 4
> 2 v i r u s e s 3 7 54402
*Enumerates persons in which >1 virus was identified. Numbers above empty cells represent community-acquired acute gastroenteritis (AGE) cases; 
numbers below the line represent healthcare-associated AGE cases. NHS, National Health Service.RESEARCH
symptoms among children with HA viral gastroenteritis was 
8 days (range 2–1,365 days); two thirds of infections oc-
curred at least 1 week after hospital admission.
Discussion
In our study, one ﬁ  fth of AGE among children within 
a large pediatric hospital was of viral origin and acquired 
within the healthcare setting. Furthermore, at least 1 virus 
was detected in >50% of HA-AGE patients, and in 28%, 
>1 virus was identiﬁ  ed. HA viral gastroenteritis is a ma-
jor infection control issue in hospital pediatric wards (19). 
Our study systematically detected each of the 5 established 
causes of viral gastroenteritis.
Rotavirus was the most common virus identiﬁ  ed 
among children with CA- and HA-AGE (43% and 31%, 
respectively). It was also the virus most likely to occur 
alone and was the virus with which severe symptoms 
were most often associated. A recent review of European 
studies identiﬁ  ed rotavirus in 31%–87% of all-cause HA-
AGE, reﬂ  ecting the differences in methods used in indi-
vidual studies (4). HA rotavirus infections in our study 
accounted for 32% of all rotavirus infections identiﬁ  ed. 
This  ﬁ   nding is consistent with 2 recent retrospective 
studies showing that 21% (20) and 36% (21) of rotavirus 
gastroenteritis cases were HA and 2 reviews document-
ing that 14%–51% of rotavirus infections among hospital-
ized children were HA (3,5). Therefore, the impact of HA 
rotavirus gastroenteritis in major pediatric hospitals has 
not decreased since the ﬁ  rst major study of this subject 
published nearly 20 years ago (22).
With the availability and application of molecular as-
says capable of detecting a broad range of norovirus gen-
otypes, norovirus is now recognized as a major cause of 
sporadic CA-AGE in children (23–25). We document that 
norovirus was the second most common virus identiﬁ  ed 
(after rotavirus) among children with HA-AGE (detected 
in 16% of HA-AGE patients and in 24% of HA-AGE pa-
tients in whom a single virus was identiﬁ  ed). Furthermore, 
norovirus was associated with severe illness in a substan-
tial percentage (24%) of HA-AGE patients in which it was 
identiﬁ  ed as a sole infection, a percentage similar to that 
obtained for rotavirus (36%).
Previous studies have investigated adenovirus 40/41 in 
CA-AGE, and we systematically looked for it in children 
with HA-AGE. Adenovirus 40/41 was the third most com-
monly identiﬁ  ed virus in our study among children with 
CA- and HA-AGE (detected in 14% and 15% of patients, 
respectively). Studies that have investigated for adenovi-
rus 40/41 among children with CA-AGE by using antigen-
based detection methods have generally reported detection 
rates of ≈5% (1). We used molecular methods, therefore 
suggesting a greater role for adenovirus 40/41 in CA-AGE 
than has been previously appreciated, and now indicating it 
also plays a prominent role in HA-AGE. Notably, adenovi-
rus 40/41 was also the third most commonly identiﬁ  ed en-
teric virus in a recent study in East Anglia, UK where it was 
detected by PCR in 9.6% of all children examined (10). 
Astroviruses and sapoviruses were much less frequently 
identiﬁ  ed in our study, despite the application of molecular 
methods.
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Table 4. Median AGE severity scores among children 
hospitalized at Alder Hey Hospital for HA-AGE versus CA-AGE, 
by types of viruses detected, Liverpool, UK, 2006–2007* 
Virus
HA-AGE, n = 225 
(range) 
CA-AGE, n = 351 
(range) 
Rotavirus 8 (3–17)  8 (2–16) 
Norovirus 8 (3–14)  9 (2–15) 
Adenovirus 40/41  6 (3–12)  6 (4–14) 
Astrovirus 7.5 (6–9)  7.5 (5–11) 
Sapovirus 11 (11)  5 (4–8) 
Any virus detected  8 (3–17)  8 (2–16) 
No virus detected  7 (3–15)  7 (2–15) 
*CA-AGE, community-acquired acute gastroenteritis; HA-AGE, healthcare-
associated acute gastroenteritis. 
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Figure 1. Phylogenetic tree based on viral protein (VP) 7 nucleotide 
sequences of serotype G1 rotavirus strains from Royal Liverpool 
Children’s National Health Service Foundation Trust (Alder Hey 
Hospital), Liverpool, UK. For each strain the source (healthcare-
associated [HA] or community-acquired [CA]), specimen number, 
month/year of detection, and name of the strain is indicated. 
Reference G1P[8] strain Wa is included. Horizontal lengths are 
proportional to the genetic distance calculated with Kimura’s 
2-parameter method. Scale bar shows genetic distance expressed 
as nucleotide substitutions per site. Bootstrap probabilities >80% 
(>800 of 1,000 pseudoreplicate trials) are indicated at each node. 
Hatched VP7 sequences are from strains whose electropherotypes 
shared an identical L1 pattern. The VP7 nucleotide sequences 
used in the tree have been deposited under the strain name 
and accession number (in parentheses) as follows; 06AH001 
(FJ797814), 06AH005 (FJ797815), 06AH033 (FJ797816), 06AH037 
(FJ797817), 06AH041 (FJ797818), 06AH043 (FJ797819), 06AH047 
(FJ797820), 06AH077 (FJ797821), 06AH083 (FJ797822), 06AH099 
(FJ797823), 06AH143 (FJ797824), 06AH161 (FJ797825), 06AH167 
(FJ797826), 06AH175 (FJ797827), 06AH218 (FJ797828), 07AH441 
(FJ797829), 07AH451 (797830), 07AH466 (FJ797831), 07AH467 
(FJ797832), 07AH468 (FJ797833) , 07AH490 (FJ797834), 07AH491 
(FJ797835), 07AH500 (FJ797836), 07AH506 (FJ797837), 07AH508 
(FJ797838), 07AH517 (FJ797839).Viral Gastroenteritis among Hospitalized Children
With the use of molecular methods to detect 5 estab-
lished viral agents of gastroenteritis, we demonstrated that 
15% of HA-AGE patients contained >1 virus, emphasiz-
ing the value of the simultaneous examination for multiple 
viruses. Thus, in a recent community-based study in the 
United Kingdom that examined for each of these 5 viruses 
using molecular assays, mixed virus infections were identi-
ﬁ  ed in 11.7% of case-patients (24). In almost 50% of the 
norovirus infections in our study, an additional virus was 
identiﬁ  ed (most commonly rotavirus). Although we found 
no evidence of increased disease severity among rotavirus–
norovirus co-infections (data not shown), our data clearly 
demonstrate the frequency with which both viruses cocir-
culate with the potential for nosocomial spread. Dual noro-
virus–rotavirus co-infections were also commonly recog-
nized in a recent study of hospitalized children in Italy, in 
whom the severity of illness was higher than with norovirus 
infection alone (26). Similar to the observations made for 
norovirus, additional virus infections were commonly iden-
tiﬁ  ed among case-patients excreting adenovirus 40/41, in 
whom more than half had additional viruses.
Although each of the enteric viruses detected in this 
study is ﬁ  rmly established as a gastroenteritis pathogen, the 
detection of a virus in a child with AGE does not neces-
sarily imply causation. This is most clearly relevant in the 
context of co-infections including mixed virus infections, 
where >1 detected organisms may not be primarily respon-
sible for diarrhea. Although we did not exhaustively and 
systematically search for other potential infective causes of 
diarrhea, we identiﬁ  ed enteropathogenic bacteria and para-
sites in <2% of specimens examined, which suggests that 
they were not major causes of diarrhea in our study popu-
lation (data not shown). Additionally, although detection 
of a virus by a sensitive molecular method may be more 
likely than a less sensitive antigen-based assay to indicate 
subclinical infection (27), prolonged rotavirus shedding 
demonstrated by RT-PCR was associated with symptoms 
of diarrhea in a longitudinal study of children recovering 
from severe rotavirus infection (28). Because molecular-
based assays are widely accepted as the preferred detec-
tion method for norovirus, but not for other gastroenteritis 
viruses, application in this study of molecular methods that 
likely have similar (high) levels of sensitivity for detec-
tion of all 5 gastroenteritis viruses allowed more appropri-
ate recognition of the extent of virus circulation within the 
hospital. Finally, although a stool sample obtained from a 
patient at hospital admission would be required to conclu-
sively categorize a viral gastroenteritis episode as CA or 
HA, two thirds of these infections occurred >1 weeks after 
admission, and a 48-hour symptom-based deﬁ  nition has 
been used extensively in previous studies (3–5).
The entry and spread of enteric viruses into and within 
pediatric healthcare settings is not completely understood. 
Several studies have indicated that multiple rotavirus in-
troductions from the community into the hospital and sub-
sequent spread between patients accounts for most HA 
rotavirus infections because of the diversity among strains 
recovered from hospitalized children and similarity at the 
genotype level between viruses circulating within the com-
munity and hospital (20,29,30). Similarly, a recent study 
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Figure 2. Phylogenetic tree based on 387 nucleotide sequences 
of the 5′ end of open reading frame 2 (encoding viral protein 1) of 
norovirus strains from Royal Liverpool Children’s National Health 
Service Foundation Trust (Alder Hey Hospital), Liverpool, UK. For 
each strain the source (healthcare-associated [HA] or community-
acquired [CA]), specimen number, month/year of detection, and the 
name of the strain is indicated. Reference strains included on the tree 
are GII/1 U07611 Hawaii/71/US, GII/2 X81879 Melksham/89/UK, 
GII/3 U22498 Mexico/89/MX, GII/4 X86557 Lordsdale/93/UK, GII/5 
AJ277607 Hillingdon/90/UK, GII/6AB039776 SaitamaU3/97/JP, 
GII/7 AJ277608 Leeds/90/UK, GII/8 AB067543 SaitamaU25/98/JP, 
GII/9 AY054299 IdahoFalls/378/96/US, GII/10 AY237415 Mc37/99/
Thai, GII/11 AB112221 SaitamaT29GII/01/JP, GII/12 AB039775 
SaitamaU1/97/JP, GII/13 AY130761 M7/99/US, GII/14 AB078334 
Kashiwa47/00/JP, GII/15 AB058582 SaitamaKu80aGII/99/JP, GII/16 
AB112260 SaitamaT53GII/02/JP, GII/17 AF195847 Alphatron/98/
NE, GI/1 M87661 Norwalk/68/US, AJ313030 Queen’sArms/
Leeds/92/UK, AJ277615 Sindlesham/95/UK. Horizontal lengths 
are proportional to the genetic distance calculated with the Kimura 
2-parameter method. Scale bar shows genetic distance expressed 
as nucleotide substitutions per site. Bootstrap probabilities >80% 
(>800 of 1,000 pseudoreplicate trials) are indicated at each node. 
The nucleotide sequences used in the tree have been deposited 
under the strain name and accession number (in parentheses) as 
follows; 06AH107 (FJ797840), 06AH109 (FJ797841), 06AH187 
(FJ797842), 06AH194 (FJ797843), 06AH225 (FJ797844), 06AH387 
(FJ797845), 06AH395 (FJ797846), 06AH397 (FJ797847), 06AH040 
(FJ797848), 06AH402 (FJ797849), 06AH406 (FJ797850), 06AH408 
(FJ797851), 06AH410 (FJ797852), 07AH448 (FJ797853), 06AH050 
(FJ797854), 07AH509 (FJ797855), 07AH517 (FJ797856) 07AH525 
(FJ797857), 07AH551 (FJ797858), 07AH570 (FJ797859), 07AH571 
(FJ797860), 07AH579 (FJ797861), 07AH590 (FJ797862), 07AH602 
(FJ797863), 07AH604 (FJ797864), 07AH611 (FJ797865), 07AH612 
(FJ797866), 07AH616 (FJ797867), 07AH619 (FJ797868), 07AH623 
(FJ797869), 07AH633 (FJ797870), 07AH642 (FJ797871), 07AH643 
(FJ797872), 07AH651 (FJ797873), 07AH653 (FJ797874), 07AH654 
(FJ797875), 06AH097 (FJ797876).RESEARCH
that described frequent, brief clusters of norovirus gastro-
enteritis among pediatric inpatients attributed these ﬁ  nd-
ings to frequent introduction of noroviruses into the hos-
pital from the community (31). For both rotaviruses and 
noroviruses, however, previous studies have not provided 
direct evidence that strains detected among hospitalized 
children originated in the community. In this respect, our 
study provides strong molecular epidemiologic support, at 
the nucleotide level, for the hypothesis that rotaviruses and 
noroviruses in the community are the sources of HA in-
fection. Thus, rotaviruses (judged by VP7 sequence), and 
noroviruses (examined by sequence of the capsid region) 
detected among HA-AGE cases were similar or identical to 
corresponding viruses detected in children with CA-AGE.
In contrast to CA-AGE cases, the highest rates of HA- 
viral enteric infections did not occur on the acute medi-
cal and surgical wards but instead in the critical care areas, 
neurologic, cardiac, and long stay wards where chronically 
ill children are patients. We observed this trend for each 
of the 3 major viruses identiﬁ  ed (rotavirus, norovirus, and 
adenovirus 40/41). Although we noticed differences in the 
hospital distribution of HA-AGE cases, the ages of children 
with HA-AGE did not differ signiﬁ  cantly from children 
with CA-AGE. We did, however, ﬁ  nd evidence for severe 
disease among 28% of children with HA viral gastroenteri-
tis in our study; 22% of such children had an underlying 
medical condition (data not shown). Given that CA viruses 
are likely to be the source of HA viral gastroenteritis, stan-
dard hospital infection prevention measures (e.g., isolation 
of children with AGE) should be emphasized (32). Hand 
washing by staff before patient contact may be particularly 
important because asymptomatic staff members could be a 
source of HA rotavirus infection (33) and hand washing has 
been shown to reduce the rate for nosocomial rotavirus in-
fection (34). However, because HA rotavirus infection re-
mains a substantial clinical problem ≈20 years after publi-
cation of a seminal study on the subject (22), even stringent 
infection control precautions are likely to be insufﬁ  cient to 
greatly reduce the problem. In the context of rotavirus, the 
major pathogen responsible for CA- and HA-AGE, rotavi-
rus vaccines offer a further opportunity to reduce the im-
pact of HA-AGE. Routine rotavirus vaccination of children 
in the community is expected to greatly reduce the num-
ber of CA, rotavirus-associated hospitalizations (35,36), 
thereby reducing the hospital rotavirus reservoir and HA 
rotavirus gastroenteritis. The prevention of HA rotavirus 
gastroenteritis should represent an important secondary 
goal of rotavirus vaccines (3,6).
In conclusion, we have demonstrated that viruses ac-
counted for more than half the cases of HA-AGE in a large 
pediatric hospital and resulted from the frequent introduc-
tion of gastroenteritis viruses from the community. Be-
cause rotavirus is the single most common pathogen, intro-
duction of a rotavirus vaccine into childhood immunization 
programs is expected to substantially reduce the incidence 
of CA and HA rotavirus gastroenteritis in hospitals.
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